The combined evidence of peer-reviewed publications, first-hand observation of raw data and discussions with the Australian scientists was persuasive to Fermiscan that such hair analyses may have significant potential to be used as a simple, non-invasive screening method for breast cancer.

Fermiscan results published in 2008

The International Journal of Cancer published a landmark scientific paper that supports the potential of Fermiscan's technology to detect the presence of breast cancer using hair samples. The results appeared in the February 2008 edition of the journal, titled 'Diagnosis of breast cancer by X-ray diffraction of hair' (volume 122, pages 847-856).

The paper's authors, Fermiscan's scientists Gary Corino and Peter French, used two different synchrotron beamlines at the Advanced Photon Source in Chicago, USA. The article reports on the replication of the original finding of the inventor - that the structure of hair changes with the development of breast cancer.

In 2008 Fermiscan completed a 2,000 patient blind clinical trial (validation trial) comparing the Fermiscan Test to current breast screening methods of mammography and ultrasound (and any subsequent biopsy and pathology). The trial confirmed the ability of the Fermiscan Test to detect the presence of a breast cancer using X-ray diffraction.

To access Key Scientific Papers 1999-2008 click here

Fermiscan Scientific Reports:

2007 Science Report - page 5 Annual Report

2006 Science Report - page 6 Annual Report